Volume 68 | January 31, 2023
| |
A program of NIH’s National Center for Advancing Translational Sciences | |
Sites with Signed
DUAs
370
| |
Sites Sharing Data with N3C
234
| |
COVID-19
Positive
Patients
8,661,052
| |
Rows
of Patient
Data
30.8 billion
| |
Approved
N3C Research
Projects
527
| |
As we reflect on 2023, it is with immense enthusiasm that N3C presents the '2023 Year in Review.' The past year has been a testament to collaborative team science and realizing accessible real-world data, and the community has made terrific progress in planning for the future. To view a snapshot of N3C’s remarkable achievements, click the button below. | |
What the Research Community is Saying about N3C | |
Joey P. Johnson, MD, FAAOS
Associate Professor
Director of Clinical Research
Department of Orthopedic Surgery
University of Alabama at Birmingham
| |
The N3C collective allowed myself and my collaborators to gain a better understanding of how COVID-19 impacts the outcomes of orthopedic trauma patients on a national scale. The N3C allowed us the unique ability to leverage large scale data to determine how COVID changed the outcomes of inpatient fracture care in “Association between COVID-19 and Mortality in Hip Fracture Surgery in the National COVID Cohort Collaborative (N3C)” and “Outcomes of SARS-CoV-2 Infection Among Patients with Orthopaedic Fracture Surgery in the National COVID Cohort Collaborative (N3C)”, both of which were published in internationally recognized journals. | |
To help our community with a positive and productive workload, N3C schedules several “No Meeting Weeks” throughout the year.
N3C support will continue with regular operations during these dates. Most meetings will be canceled. Impromptu meetings can still occur to push through action items as needed during no meeting week. Workgroups and Domain Teams should check with their Leads to determine meeting schedules for that week.
| |
Upcoming N3Community Forums
*UPDATE*
Effective February 1, the N3Community Forum will move to once a month. Forums will take place on the 2nd Monday of each month at 2 pm PT / 5 pm ET.
Register for the Forum
| |
Missed an N3Community Forum or want to revisit a past Forum? You can find all the videos on our YouTube page.
Share your thoughts: Looking for ways to bring relevant and exciting presentations to the Forum. Let us know if there are topics, presentations, or speakers you would like to see: bit.ly/N3CForumFeedback
| |
|
Doctors Aren’t Prescribing Paxlovid Often Enough. Here’s Why
Covid-19 infections and deaths have been steadily increasing in recent weeks, now reaching 1,500 deaths per week. There are antiviral drugs that still protect against severe infection and death, yet practitioners prescribe them infrequently. Why?
| | | |
Planning to Publish or Present Research Results? Here's how to find the policies.
Take 1 Minute!
-
Navigate to covid.cd2h.org
- Hover over "Resources"
- Click on "Policies, Agreements, Forms"
| |
|
Check out recent N3C Publications!
Remember, if you have a potential publication that references N3C, you must submit it to the N3C Publication Committee for review. Learn more about the publication review process here: https://covid.cd2h.org/publication-review
| |
Please report any questions, gaps, or errors to [email protected] | |
Gain Access to N3C Google Drive | |
|
|
Have something you'd like featured in the N3Connect Bulletin?
Submit it to [email protected] for consideration.
| |
The National COVID Cohort Collaborative (N3C) is a complementary and synergistic partnership among the Clinical and Translational Science Awards (CTSA) Program hubs, the National Center for Data to Health (CD2H), distributed clinical data networks (PCORnet, OHDSI, ACT, TriNetX), and other partner organizations, with overall stewardship by NIH’s National Center for Advancing Translational Sciences (NCATS). The N3C aims to improve the efficiency and accessibility of analyses using a very large row-level (patient-level) COVID-19 clinical dataset, demonstrate a novel approach for collaborative pandemic data sharing, and speed understanding of and treatments for COVID-19. | |
CD2H is supported by the National Center for Advancing Translational Sciences (NCATS)
at the National Institutes of Health
(Grant U24TR002306).
| | | | | |